Mylan Recalls Rifampin Injection Vials Due to Impurity Concerns
Mylan Laboratories is recalling 19,165 vials of Rifampin for Injection due to elevated unknown impurities that may reduce product effectiveness.
- Product
- RIFAMPIN — RIFAMPIN (RIFAMPIN)
- Category
- Drug
- Distribution
- Distributed nationwide